Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSF1R | P07333 | 20/20 | 0.57 |
| ▸ | KIT | P10721 | 4/20 | 0.43 |
| ▸ | SRC | P12931 | 4/20 | 0.43 |
| ▸ | FLT3 | P36888 | 4/20 | 0.43 |
| ▸ | NTRK1 | P04629 | 3/20 | 0.43 |
| ▸ | INSR | P06213 | 2/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4775827 | 0.91 | CSF1R (0.59) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL4773612 | 0.86 | CSF1R (0.40) | CSF1R | |
| SCHEMBL4775794 | 0.79 | CSF1R (0.55) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL3289970 | 0.78 | CSF1R (0.65) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL3290232 | 0.78 | CSF1R (0.81) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL4775457 | 0.77 | CSF1R (0.57) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL3533106 | 0.77 | CSF1R (0.65) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL3289501 | 0.77 | CSF1R (0.65) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL3529843 | 0.76 | CSF1R (0.58) | CSF1RKITSRCFLT3NTRK1 | |
| SCHEMBL4768307 | 0.76 | CSF1R (0.47) | CSF1RKITSRCFLT3NTRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1945637-A1 | 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA N.V. (BE) | 2008-07-23 | — | — | EP | disclosed |
| WO-2007033137-A1 | 5-OXO-5,8-DIHYDRO-PYRIDO-PYRIMIDINES AS INHIBITORS OF C-FMS KINASE | JANSSEN PHARMACEUTICA, N.V. (BE) | 2007-03-22 | — | — | WO | disclosed |